MITRO Biotech Co., Ltd.

MITRO Biotech is a specialized Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) focused on radiolabeling and molecular imaging. The company provides comprehensive, one-stop solutions for drug discovery, biodistribution, pharmacokinetics, and pharmacodynamics, supporting global pharmaceutical and biotechnology companies in accelerating the development of innovative radiopharmaceuticals. Headquartered in Nanjing, China, with an expanding international presence including operations in the United States and the United Kingdom, MITRO leverages advanced molecular imaging technologies to support research across oncology, neurology, and cardiovascular diseases. The company operates state-of-the-art, AAALAC-accredited animal facilities and maintains a network of PET production centers to facilitate multi-center clinical trials.